Published in Am Rev Respir Dis on October 01, 1981
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest (1989) 1.23
Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest (2007) 1.18
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest (1985) 1.11
Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study. Respir Res (2008) 1.11
The late reaction following bronchial provocation with house dust mite allergen. Dependence on arachidonic acid metabolism. Clin Exp Immunol (1983) 1.10
Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol (2002) 1.09
Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol (1985) 1.09
Prostaglandin D₂ and T(H)2 inflammation in the pathogenesis of bronchial asthma. Korean J Intern Med (2011) 0.98
Thromboxane A2 moderates permeability after limb ischemia. Ann Surg (1985) 0.97
Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax (1986) 0.97
Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest (1988) 0.95
PGI2 as a regulator of inflammatory diseases. Mediators Inflamm (2012) 0.94
Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest (1982) 0.93
Determinants of cardiovascular stability during abdominal aortic aneurysmectomy (AAA). Ann Surg (1984) 0.93
Effect of aspirin in "aspirin sensitive" patients. Br Med J (Clin Res Ed) (1984) 0.90
Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg (1989) 0.88
The role of prostaglandins in allergic lung inflammation and asthma. Expert Rev Respir Med (2014) 0.87
Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. J R Soc Med (1995) 0.85
Congenital diaphragmatic hernia: association between pulmonary vascular resistance and plasma thromboxane concentrations. Arch Dis Child (1984) 0.83
Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate. Br J Pharmacol (1985) 0.82
BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. Br J Pharmacol (1991) 0.82
Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung. Br J Pharmacol (1984) 0.81
Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. Br J Pharmacol (1986) 0.81
Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. J Clin Invest (1991) 0.80
Effects of prostaglandins E1, E2, and F2 alpha on mucin secretion from human bronchi in vitro. Thorax (1984) 0.80
Release of arachidonic acid metabolites and histamine from sensitized guinea-pig lung following antigen challenge. Br J Pharmacol (1988) 0.80
Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J Clin Invest (1990) 0.80
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets. Curr Allergy Asthma Rep (2016) 0.78
Effect of prostaglandin D2 on histamine-induced weals in human skin. Br J Pharmacol (1986) 0.78
Contribution of thromboxane A2 to the antigen-induced immediate asthmatic response mediated by IgG1 antibody by augmentation of bronchial responsiveness in guinea-pigs. Br J Pharmacol (1994) 0.77
Effect of OKY 046, a thromboxane synthase inhibitor, on lung vascular permeability after pulmonary embolism in sheep. Thorax (1987) 0.75
Cyclic-AMP mediated drugs: differential or global reduction of eicosanoid synthesis in the isolated rat lung? Mediators Inflamm (1992) 0.75
Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease. J Cytokine Biol (2017) 0.75
Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69
Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med (1974) 4.31
Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics (1996) 3.59
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Evidence for individual human peripheral blood lymphocytes bearing both B and T cell markers. Nature (1974) 3.12
New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem (1999) 2.97
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol (1975) 2.74
Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis (1983) 2.37
A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods (1997) 2.35
Calcium supplementation and bone mineral density in adolescent girls. JAMA (1993) 2.14
Seizures in a patient treated with continuous povidone-iodine mediastinal irrigation. N Engl J Med (1992) 2.07
Effects of colchicine on IgE-mediated early and late airway reactions. Chest (1995) 2.06
Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest (1975) 2.04
Socioeconomic status and race as risk factors for cockroach allergen exposure and sensitization in children with asthma. J Allergy Clin Immunol (1996) 2.03
Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta (2000) 1.95
Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med (1985) 1.84
Human lung mast cells: purification and characterization. J Immunol (1982) 1.78
Generation of leukotrienes by purified human lung mast cells. J Clin Invest (1982) 1.77
House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol (2001) 1.73
IgE receptors on human basophils. Relationship to serum IgE concentration. J Clin Invest (1978) 1.71
IgE responses in human filariasis. I. Quantitation of filaria-specific IgE. J Immunol (1981) 1.71
Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol (1977) 1.63
Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med (1989) 1.62
Routine use of penicillin skin testing on an inpatient service. N Engl J Med (1971) 1.58
The radioallergosorbent test: Uses and abuses. J Allergy Clin Immunol (1980) 1.54
High-titer protamine-specific IgG antibody associated with anaphylaxis: report of a case and quantitative analysis of antibody in vasectomized men. Anesthesiology (1993) 1.54
Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem (1983) 1.52
Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae. J Gen Microbiol (1987) 1.52
Natural rubber latex skin testing reagents: safety and diagnostic accuracy of nonammoniated latex, ammoniated latex, and latex rubber glove extracts. J Allergy Clin Immunol (1996) 1.49
Arachidonic acid metabolism in purified human lung mast cells. J Immunol (1984) 1.47
Collateral ventilation in man. N Engl J Med (1978) 1.47
Diagnosis of natural rubber latex allergy: multicenter latex skin testing efficacy study. Multicenter Latex Skin Testing Study Task Force. J Allergy Clin Immunol (1998) 1.47
Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J Immunol (1983) 1.47
Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy (1988) 1.47
Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease. Clin Exp Allergy (2009) 1.46
Allergy to insect stings. II. Phospholipase A: the major allergen in honeybee venom. J Allergy Clin Immunol (1976) 1.45
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest (1985) 1.45
Risk factors for drug allergy. J Allergy Clin Immunol (1984) 1.43
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest (1983) 1.41
Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med (1981) 1.40
Bioavailable testosterone in salivary glands. Clin Chem (1991) 1.39
Monoclonal antibodies to lutropin: are our immunoassays too specific? Clin Chem (1991) 1.38
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med (1984) 1.38
Heterogeneity of human mast cells. J Immunol (1983) 1.37
Albumin stabilizes leukotriene A4. J Biol Chem (1982) 1.35
Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest (1980) 1.32
Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA (1993) 1.32
Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila) (2009) 1.32
Faster enzymatic procedure for serum triglycerides. Clin Chem (1975) 1.29
International Consensus on drug allergy. Allergy (2014) 1.29
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem (2002) 1.29
The radioallergosorbent test in 1981--limitations and refinements. J Allergy Clin Immunol (1981) 1.29
Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages. Biochem Biophys Res Commun (1995) 1.28
Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol Pharmacol (2002) 1.28
The bifunctional enzyme leukotriene-A4 hydrolase is an arginine aminopeptidase of high efficiency and specificity. J Biol Chem (1994) 1.27
Inhibition of phospholipase C dependent processes by U-73, 122. Adv Prostaglandin Thromboxane Leukot Res (1989) 1.27
Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J Biol Chem (1991) 1.26
Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab (2000) 1.26
Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab (1991) 1.24
Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem (1986) 1.23
In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res (1998) 1.21
Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization. J Clin Invest (1979) 1.20
Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis (2006) 1.20
Separation of slow reacting substance of anaphylaxis (SRS-A) from human lung into four biologically active fractions. J Immunol (1976) 1.19
Allergic reactions to drugs and biologic agents. JAMA (1987) 1.19
Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat. Am J Physiol (1983) 1.19
The quantitation of parasite-specific human IgG and IgE in sera: evaluation of solid-phase RIA and ELISA methodology. J Immunol Methods (1981) 1.16
Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene (2007) 1.15
Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J Biol Chem (2001) 1.15
Basophil and mast cell degranulation: ultrastructural analysis of mechanisms of mediator release. Fed Proc (1983) 1.15
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis (1982) 1.14
Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem (2010) 1.13
Organ culture of human endometrium. Effect of ovarian steroids. Am J Obstet Gynecol (1969) 1.13
6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies. Prostaglandins (1982) 1.12
Virus and interferon effects on cellular prostaglandin biosynthesis. J Immunol (1980) 1.12
Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis. Ann Oncol (2004) 1.11
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest (1985) 1.11
Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J Biol Chem (1991) 1.11
Lymphocytes in patients with variable immunodeficiency and panhypogammaglobulinemia. Evaluation of B and T cell surface markers and a proposed classification. J Clin Invest (1974) 1.11
Comparative studies of human basophils and mast cells. Fed Proc (1983) 1.11
Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab (1985) 1.11
Antigenic analysis of household dust samples. Am Rev Respir Dis (1988) 1.11
The effect of cat removal on allergen content in household-dust samples. J Allergy Clin Immunol (1989) 1.11
Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis (1977) 1.10
Influence of mineral dust surface chemistry on eicosanoid production by the alveolar macrophage. J Toxicol Environ Health (1992) 1.10
Effect of prolonged exercise on plasma prostaglandin levels. Prostaglandins Med (1981) 1.10
Cross-allergenicity and immunogenicity of aztreonam. Rev Infect Dis (1986) 1.10
Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature (1985) 1.09
Anaphylactic release of prostaglandins from human lung in vitro. Am Rev Respir Dis (1980) 1.08
Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci U S A (1986) 1.08
Dysmenorrhea and prostaglandins. Obstet Gynecol Surv (1976) 1.08